Resource Library

San Francisco, CA (August 19, 2022) — Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions.

Smart IP Packaging Helps Clinical Trials Avoid Supply Chain Hurdles to Study Startup Ian Davison, Ph.D. Neuroscience, Medrio’s In-house RTSM Subject Matter Expert Packaging decisions may seem benign, but they...

The Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy Medrio’s eConsent module in less than two weeks to support its remote study to...

In this episode, we discuss with Kafayat Babajide, Director of Patient Insights & Experience with Johnson and Johnson, the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process.

In this episode, Rose Gerber, Director of Patient Advocacy and Education at the Community Oncology Alliance – once a patient herself and now a dedicated advocate – will share her story.

In this podcast we are joined by Kimberly Richardson, Patient Advocate and Cancer Survivor, to discuss how we can work towards achieving health equity in the United States, what steps can be taken today, and the impact this would have on clinical research.